Speaker: Date: Topic
Sanjiv Chopra, MD
Mar. 5, 2014
Chronic Hepatitis C: A Multifaceted Disease
CDC Recommendations for Prevention and Control
Responsibility for Content
The WebEx video, PowerPoint presentation, take-away points, and article links were sent by the Medical Library and the CME Committee.
Diane E. Young, Information Specialist
Take-Away Points of the Presentation
1. New CDC recommendation to screen all baby boomers for Chronic Hepatitis C infection.
2. We have entered a new era--game changers--for the treatment of Chronic Hepatitis C.
3. New treatments are of shorter duration but more expensive.
4. New combination oral treatments (no interferon) are on the horizon.
5. Cure rates will approach 95 - 100 %.
Links to Articles Cited in the Presentation
- 1) Alter MJ: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.
- 2) Simmonds P: Viral heterogeneity of the hepatitis C virus. J Hepatol 1999;31 Suppl 1:54-60.
- 3) Kiyosawa K: Transmission of hepatitis C in an isolated area in Japan: community-acquired infectio
- 4) Frank C: The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Eg
- 5) Terrault NA: Sexual activity as a risk factor for hepatitis C. Hepatology 2002;36(5 Suppl1):S99-1
- 6) Roberts EA: Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002;36(5 Sup
- 7) Poynard T: Natural history of liver fibrosis progression in patients with chronic hepatitis C. Th
- 8) Gumber SC & Chopra S: Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations.
- 9) Cacoub P: Extrahepatic manifestations associated with hepatitis C virus infection (Pt 1). A prosp
- 91) Cacoub P: Extrahepatic manifestations associated with hepatitis C virus infection (Pt 2). A pros
- 92) Cacoub P: Extrahepatic manifestations associated with hepatitis C virus infection (Pt 3). A pros
- 93) Johnson RJ: Membranoproliferative glomerulonephritis associated with hepatits C virus infection
- 93) Sansonno D: Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected
- 94) Cacoub P: Systemic vasculitis in patients with hepatitis C. J Rheumatol 2001;28(1):109-18.
- 95) Mendez P: Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and se
- 96) Mehta SH: Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection
- 97) Shintani Y: Hepatitis C virus infection and diabetes: direct involvement of the virus in the dev
- 98) Rasul I: Detection of occult low-grade b-cell non-Hodgkin's lymphoma in patients with chronic he
- 99) Quinn ER: The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds
- 991) Marcellin P: Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in pa
- 992) Van der Meer AJ: Association between sustained virological response and all-cause mortality amo
- 993) Poordad F & Dieterich D: Treating hepatitis C: current standard of care and emerging direct-act